Medic Vision is exhibiting at the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016) and will be highlighting its SafeCT-29 product.

High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer control rates, according to new research. The findings were presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston. The study is the first large, multi- institutional study of SBRT in prostate cancer with long-term follow-up.

Elekta announced recently that its high-field magnetic resonance linear accelerator (MR-linac) was the focus of multiple presentations at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting, held Sept. 25 – 28 in Boston. Additional abstracts presented by members of Elekta’s MR-linac Consortium also highlighted the need for adaptation of radiation therapy to address moving tumors and nearby organs during treatment sessions. Naturally occurring physiological movements currently limit the ability to conform the treatment to the target and increase exposure of radiation to healthy tissues.

October 6, 2016 — Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago.

Using anonymized data collected by the Radimetrics Enterprise Platform we identified a customer with a contrast dose outlier and initiated an investigation to gain further insight.

aycan recently introduced aycan store VNA, a vendor neutral archiving (VNA) and distribution system that helps healthcare organizations be more efficient with the management and sharing of images and other data.

The American College of Radiology (ACR) announced in a recent statement that if Congress does not act, millions of women may lose insurance coverage for annual mammograms. Patient groups, minority healthcare advocates and breast cancer experts are urging Congress to extend a federal mandate that effectively requires insurers to fully cover annual screening mammograms for women ages 40 and older.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now